SCHEMBL6650281

SCHEMBL6650281

C[C@H](NC(=O)c1c(CBr)c(-c2ccccc2)nc2ccccc12)C1CCCCC1.Cc1c(-c2ccccc2)nc2ccccc2c1C(=O)O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TACR3 P29371 13/20 0.64
TACR2 P21452 12/20 0.64
OPRM1 P35372 6/20 0.64
CYP2C9 P11712 4/20 0.61
TSHR P16473 2/20 0.54
PDE10A Q9Y233 2/20 0.54
DHODH Q02127 2/20 0.52
MEN1 O00255 1/20 0.50
ALDH1A1 P00352 1/20 0.50
TP53 P04637 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
NFKB1 P19838 1/20 0.50
MAPK1 P28482 1/20 0.50
CYP2C19 P33261 1/20 0.50
BLM P54132 1/20 0.50
PMP22 Q01453 1/20 0.50
KMT2A Q03164 1/20 0.50
ATM Q13315 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5420737 0.94 TACR3 (0.71) TACR3TACR2OPRM1CYP2C9TRPV4
SCHEMBL5425877 0.89 CYP2C9 (0.75) TACR3TACR2OPRM1CYP2C9TSHR
SCHEMBL5909008 0.83 TACR3 (0.68) TACR3TACR2OPRM1CYP2C9TRPV4
SCHEMBL5908992 0.83 TACR3 (0.68) TACR3TACR2OPRM1CYP2C9TRPV4
SCHEMBL4667064 0.83 TACR3 (0.67) TACR3TACR2OPRM1CYP2C9TRPV4
SCHEMBL1581445 0.82 TACR3 (0.69) TACR3TACR2OPRM1CYP2C9TRPV4
SCHEMBL14564772 0.82 CYP2C9 (0.77) TACR3TACR2OPRM1CYP2C9TRPV4
SCHEMBL8268049 0.81 TACR3 (0.68) TACR3TACR2OPRM1CYP2C9TRPV4
SCHEMBL1581261 0.81 TACR3 (0.68) TACR3TACR2OPRM1CYP2C9TRPV4
SCHEMBL1580919 0.81 TACR3 (0.67) TACR3TACR2OPRM1CYP2C9TRPV4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1385839-A1 3-SUBSTITUTED QUINOLINE-4-CARBOXAMIDE DERIVATIVES AS NK-3 AND NK-2 RECEPTOR ANTAGONISTS GlaxoSmithKline S.p.A. (IT) 2004-02-04 EP disclosed
WO-2002083664-A1 3-SUBSTITUTED QUINOLINE-4-CARBOXAMIDE DERIVATIVES AS NK-3 AND NK-2 RECEPTOR ANTAGONISTS GLAXOSMITHKLINE S.P.A. (IT) 2002-10-24 WO disclosed